E-LIB Suche - Ergebnisse für: Pazo Cid, R.A.

1

395MO Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PB..:

Raymond, E. ; Xu, J. ; Kato, K....
Annals of Oncology. 35 (2024) - p. S159 , 2024

Link: https://doi.org/10.1016/..

2

323P NALIRIFOX versus nab-paclitaxel and gemcitabine (Gem+N..:

Macarulla Mercade, T. ; Pazo Cid, R.A. ; Womack, M....
Annals of Oncology. 35 (2024) - p. S135-S136 , 2024

Link: https://doi.org/10.1016/..

3

331P Phase Ib/IIa study to evaluate safety and efficacy of ..:

Macarulla Mercade, T. ; McAndrews, K. ; Pazo Cid, R.A....
Annals of Oncology. 35 (2024) - p. S139-S140 , 2024

Link: https://doi.org/10.1016/..

4

280MO CD40 agonist mitazalimab combined with mFOLFIRINOX (m..:

Macarulla Mercade, T. ; Borbath, I. ; Geboes, K....
Annals of Oncology. 35 (2024) - p. S118 , 2024

Link: https://doi.org/10.1016/..

5

Activity of weekly paclitaxel−cetuximab chemotherapy in uns..:

Bernad, I. Pajares ; Trufero, J. Martínez ; Urquizu, L. Calera...
Clinical and Translational Oncology. 19 (2017) 6 - p. 769-776 , 2017

Link: https://doi.org/10.1007/..

6

397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo ..:

Moehler, M. ; Oh, D-Y. ; Kato, K....
Annals of Oncology. 35 (2024) - p. S160-S161 , 2024

Link: https://doi.org/10.1016/..

7

2110 Evaluation of response to sorafenib treatment in advan..:

Cid, R. Pazo ; Romera, J. Lao ; Lanzuela, M....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 171 , 2009

Link: https://doi.org/10.1016/..

8

1100 Peripheral blood lymphocite populations in advanced ga..:

Cid, R. Pazo ; Romera, J. Lao ; Lanzuela, M....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 114-115 , 2009

Link: https://doi.org/10.1016/..

9

Correction: the TEOGIC study project: a comprehensive chara..:

Vera, R. ; Castro, N. ; Labiano, I....
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

10

The TEOGIC study project: a comprehensive characterization ..:

Vera, R. ; Castro, N. ; Labiano, I....
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

11

SEOM clinical guidelines for pancreatic and biliary tract c..:

Gómez-España, Mª A. ; Montes, A. F. ; Garcia-Carbonero, R....
Clinical and Translational Oncology. 23 (2021) 5 - p. 988-1000 , 2021

Link: https://doi.org/10.1007/..

12

Biomarkers in pancreatic ductal adenocarcinoma:

Gallego, J. ; López, C. ; Pazo-Cid, R...
Clinical and Translational Oncology. 19 (2017) 12 - p. 1430-1437 , 2017

Link: https://doi.org/10.1007/..

13

SEOM clinical guideline on unknown primary cancer (2017):

Losa, F. ; Soler, G. ; Casado, A....
Clinical and Translational Oncology. 20 (2017) 1 - p. 89-96 , 2017

Link: https://doi.org/10.1007/..

14

Gene expression profiling and its use in adenocarcinomas of..:

Cebollero de Miguel, A ; Pazo Cid, R ; Martinez Trufero, J...
http://zaguan.unizar.es/record/46918. , 2015

Link: http://zaguan.unizar.es/..

15

Novel antiangiogenic therapies against advanced hepatocellu..:

Pazo-Cid, R. A. ; Lanzuela, M. ; Esquerdo, G....
Clinical and Translational Oncology. 14 (2012) 8 - p. 564-574 , 2012

Link: https://doi.org/10.1007/..